Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.

Monitor screen in radiology

Pulmonary nodules are small growths in the lung and a common incidental finding on computed tomography (CT) scans. They are mostly benign but in some cases are early lung cancers. The earlier that a lung cancer is identified and treated, the more likely the outcome will be successful. However, currently, lung nodules may need to be observed with repeat CT scans for up to two years to be able distinguish between benign and malignant nodules. A key clinical challenge is to improve the ability to predict malignancy using the initial CT scan, which would remove the diagnostic delay introduced by the need for repeat scans.

There are two types of lung cancer risk prediction models, which use either statistical approaches, such as the Brock model, or machine learning approaches such as the Lung Cancer Prediction Convolutional Neural Network, LCP-CNN developed by Oxford spin-out Optellum Ltd. The Brock model is currently recommended in clinical practice by the British Thoracic Society and incorporates patient clinical information and nodule characteristics to predict which nodules are likely to be malignant.

LCP-CNN is an externally validated artificial intelligence model that performs better than the Brock model at predicting malignancy. However, because of its AI-based nature, LCP-CNN is not fully interpretable and therefore the importance of individual parameters on the model performance are not known.

In a report published in the journal European Radiology, Dr Madhurima Chetan (Oxford University Hospitals NHS Trust) and colleagues investigated the importance of CT imaging features that contributed to the enhanced performance of LCP-CNN.

Read the full story on the Oxford Centre for Early Cancer Detection website. 

 

Related Stories:

Press Release: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Oxford study on Optellum software published in European Radiology

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.